NCT04009629

Brief Summary

Research suggests that physical exercise supports brain health and cognition as we age. The goal of this project is to examine the specific changes in brain blood flow and biological factors in the blood immediately after exercise in older adults who have the APOE4 gene, a genetic risk factor for developing Alzheimer's. Results from this study will help researchers and clinicians understand and measure changes in the body and brain as a function of exercise, and how those changes relate to Alzheimer's risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 2, 2019

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 5, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

October 25, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 28, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 28, 2021

Completed
6 months until next milestone

Results Posted

Study results publicly available

May 3, 2022

Completed
Last Updated

May 3, 2022

Status Verified

May 1, 2022

Enrollment Period

2 years

First QC Date

July 2, 2019

Results QC Date

February 9, 2022

Last Update Submit

May 2, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cerebral Blood Flow Area Under Curve

    Cumulative cerebral blood flow measured by Arterial Spin Labeling MRI. The standard arterial spin labeling unit of measure is average milliliters per 100 grams of tissue per minute (mL/100g tissue/minute). For the present analysis, we summed perfusion over the entire acquisition period, 23.2 minutes, rather than averaging. Therefore the units are milliliters per 100 grams of tissue

    ~24 minutes

Secondary Outcomes (3)

  • Insulin-like Growth Factor-1 Change

    Pre-to-post intervention (~15 minutes)

  • Vascular Endothelial Growth Factor Change

    Pre-to-post intervention (~15 minutes)

  • Brain Derived Neurotrophic Factor Change

    Pre-to-post intervention (~15 minutes)

Study Arms (2)

Exercise - apolipoprotein e4 carrier

EXPERIMENTAL

A single 15 minute bout of moderate intensity aerobic exercise for individuals with 1 or 2 copies of the APOE4 allele, the leading genetic risk factor for late-onset Alzheimer's dementia.

Behavioral: Moderate Intensity Aerobic Exercise

Exercise - apolipoprotein e4 non-carrier

EXPERIMENTAL

A single 15 minute bout of moderate intensity aerobic exercise for individuals with 0 copies of the APOE4 allele, the leading genetic risk factor for late-onset Alzheimer's dementia.

Behavioral: Moderate Intensity Aerobic Exercise

Interventions

Participants will exercise for 15 minutes in a moderate age-predicted heart rate range. The study team will employ an exercise device such as a treadmill, cycle, or recumbent stepper to maintain control over workload.

Exercise - apolipoprotein e4 carrierExercise - apolipoprotein e4 non-carrier

Eligibility Criteria

Age65 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsOlder Adult (65+)

You may qualify if:

  • Age 65-85
  • English speaking
  • Normal or corrected hearing or vision,
  • Without activity restrictions.

You may not qualify if:

  • Clinically significant cognitive or psychiatric illness,
  • Anti- coagulant use,
  • High cardiovascular risk without physician clearance for exercise,
  • Exercise-limiting musculoskeletal condition,
  • MRI contraindications

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Kansas Alzheimer's Disease Center

Fairway, Kansas, 66205, United States

Location

Related Publications (2)

  • Vidoni ED, Morris JK, Palmer JA, Li Y, White D, Kueck PJ, John CS, Honea RA, Lepping RJ, Lee P, Mahnken JD, Martin LE, Billinger SA. Dementia risk and dynamic response to exercise: A non-randomized clinical trial. PLoS One. 2022 Jul 8;17(7):e0265860. doi: 10.1371/journal.pone.0265860. eCollection 2022.

  • White D, John CS, Kucera A, Truver B, Lepping RJ, Kueck PJ, Lee P, Martin L, Billinger SA, Burns JM, Morris JK, Vidoni ED. A methodology for an acute exercise clinical trial called dementia risk and dynamic response to exercise. Sci Rep. 2021 Jun 17;11(1):12776. doi: 10.1038/s41598-021-92177-0.

Results Point of Contact

Title
Dr. Eric Vidoni
Organization
University of Kansas Medical Center

Study Officials

  • Eric D Vidoni, PT, PHD

    University of Kansas Medical Center

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Model Details: Single visit, case-control study identified as an intervention due to the use of a single bout of aerobic exercise under NIH rules (grants.nih.gov/policy/clinical-trials/definition.htm)
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 2, 2019

First Posted

July 5, 2019

Study Start

October 25, 2019

Primary Completion

October 28, 2021

Study Completion

October 28, 2021

Last Updated

May 3, 2022

Results First Posted

May 3, 2022

Record last verified: 2022-05

Data Sharing

IPD Sharing
Will share

De-identified data may be shared with unaffiliated investigators after completion of data collection and a reasonable amount of analysis and dissemination time. Contact the PI for further information.

Shared Documents
STUDY PROTOCOL, SAP, ICF, ANALYTIC CODE
Time Frame
Following a reasonable amount of analysis and dissemination time, the data will be available via request.
Access Criteria
Following institutional limits and recommendations and subject to use agreements.

Locations